Schering Deutschland GmbH

euro adhoc: Mergers - Acquisitions - Takeovers
Entry of transfer resolution of Bayer Schering Pharma AG in Commercial Register

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@



The resolution passed by the general meeting on January 17, 2007, on the transfer of the shares held by the remaining shareholders (minority shareholders) of Bayer Schering Pharma AG to Bayer Schering GmbH (principal shareholder) for an appropriate cash consideration in the amount of EUR 98.98 per share was today recorded in the company's record in the Commercial Register of the local court of Charlottenburg.

With entry of the transfer resolution in the Commercial Register all shares of the minority shareholders of Bayer Schering Pharma AG have effectively passed by operation of law to Bayer Schering GmbH. Pursuant to this, the shares held by minority shareholders substantiate exclusively entitlement to the aforementioned cash consideration.

Bayer Schering Pharma AG will shortly be withdrawn from the stock exchange.

Berlin, September 25, 2008

The Board of Management Bayer Schering Pharma AG

@@start.t2@@end of announcement                                                 euro adhoc

ots Originaltext: Schering Deutschland GmbH
Im Internet recherchierbar:

Further inquiry note:
Denise Rennmann
Head of Global Media Relations
Bayer Schering Pharma AG
Tel.: +49(0)30 468 12066
Fax:  +49(0)30 468 18195

Branche: Pharmaceuticals
ISIN:      DE0007172009
WKN:        717200
Index:    CDAX
Börsen:  Börse Berlin / regulated dealing
              Börse Hamburg / regulated dealing
              Börse Stuttgart / regulated dealing
              Börse Düsseldorf / regulated dealing
              Börse Hannover / regulated dealing
              Börse München / regulated dealing
              Börse Frankfurt / regulated dealing/general standard

Weitere Meldungen: Schering Deutschland GmbH

Das könnte Sie auch interessieren: